Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Brady Todd C
President and CEO at Aldeyra Therapeutics. Filing since 7 May 2014.
CIK 0001579179
Company
Date
Role
Action
Shares
Amount
Of holding
ALDX
Aldeyra Therapeutics, Inc.
3 Jun 2026
President and CEO
Bought
250,000
$418.45K
17.0%
ALDX
Aldeyra Therapeutics, Inc.
12 Mar 2024
President and CEO
Sold at will
85,324
$260.24K
5.5%
ALDX
Aldeyra Therapeutics, Inc.
11 Mar 2024
President and CEO
Sold at will
97,914
$320.52K
5.9%
ALDX
Aldeyra Therapeutics, Inc.
23 Jun 2022
President and CEO
Bought
17,700
$59.55K
1.5%
ALDX
Aldeyra Therapeutics, Inc.
16 Dec 2019
President and CEO
Bought
20,000
$101.91K
3.2%
ALDX
Aldeyra Therapeutics, Inc.
30 Sep 2019
President and CEO
Bought
8,710
$49.48K
1.4%
ALDX
Aldeyra Therapeutics, Inc.
23 Sep 2019
President and CEO
Bought
8,680
$50.43K
1.4%
ALDX
Aldeyra Therapeutics, Inc.
18 Sep 2019
President and CEO
Bought
14,288
$84.46K
2.4%
ALDX
Aldeyra Therapeutics, Inc.
16 Sep 2019
President and CEO
Bought
3,000
$18.09K
0.5%
ALDX
Aldeyra Therapeutics, Inc.
13 Sep 2019
President and CEO
Bought
10,000
$57.90K
1.7%
ALDX
Aldeyra Therapeutics, Inc.
10 Sep 2019
President and CEO
Bought
10,000
$53.94K
1.8%
ALDX
Aldeyra Therapeutics, Inc.
9 Sep 2019
President and CEO
Bought
10,000
$48.89K
1.8%
ALDX
Aldeyra Therapeutics, Inc.
17 Feb 2017
President and CEO
Bought
22,223
$100.00K
52.7%
ALDX
Aldeyra Therapeutics, Inc.
7 May 2014
President and CEO
Bought
12,500
$100.00K
483%
14 decisions on file.
